学术搜索
科研智能体
- Research Labs
- AI 阅读
- AI 文库
- AMiner 沉思
- AMiner 亮点
学术资源
- AI2000
- 期刊/会议
- 学者库
- 学术API
- 溯源树
- 数据集
知识沉淀
- 学术空间

订阅小程序

旧版功能

aminer vip

开通会员低至0.73元/天

一次搞定AI科研

立即登录

P. Bolin | AMiner学者主页 | AMiner

P. Bolin

East Carolina Univ

48Papers / 论文

356Citations / 引用

7H-Index

浏览量15

全面呈现 [P. Bolin] 的学术影响力

深度挖掘高质量成果与权威引用，让优秀看得见

研究兴趣

暂无数据

论文（48）

专利

基金项目

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

1Association of Tacrolimus-Level Variance with De Novo DSA within the First 2 Years after Renal Transplantation.

M. J. Everly,I. Purnajo,K. P. Briley,J. L. Beaumont,P. Bolin,S. A. Kendrick,H. Jones,K. McLawhorn,A. Q. Maldonado,D. Leeser,C. E. Haisch,L. M. Rebellato

2019AMERICAN JOURNAL OF TRANSPLANTATION（2019）

引用

加入学术空间

2A Prognostic Biomarker to Estimate the likelihood of Developing De Novo Donor Specific Antibody in Kidney Transplant Recipients.

S. Kawakita,L. M. Rebellato,K. P. Briley, A. Q. Aldonado,C. E. Haisch,P. Bolin,S. A. Kendrick,H. Jones,K. McLawhorn,D. Leeser,V. Jucaud, V. Burnett,

2019AMERICAN JOURNAL OF TRANSPLANTATION（2019）

引用

加入学术空间

3Urinary Tract Infections May Be Associated with De Novo Donor-Specific Anti-Human Leucocyte Antigen Antibodies: Single-Center Study.

M. Everly,A. Babu,K. Briley,P. Bolin,S. Kendrick,H. Jones,K. McLawhorn,A. Maldonado,C. Haisch,D. Leeser,L. Rebellato

2018AMERICAN JOURNAL OF TRANSPLANTATION（2018）

引用

加入学术空间

4All DQ DSA May Not Be Equal: Comparing Outcomes between De Novo DQ DSA Specificities.

M. Everly,K. Briley,A. Nguyen,V. Jucaud,A. Maldonado,C. Haisch,P. Bolin,S. Kendrick,H. Jones,K. McLawhorn,D. Leeser,L. Rebellato

2018AMERICAN JOURNAL OF TRANSPLANTATION（2018）引用：1

引用

加入学术空间

5Two Trajectories of Post-DSA eGFR after Kidney Transplant.

J. Beaumont,K. Briley,A. Maldonado,C. Haisch,P. Bolin,S. Kendrick,H. Jones,K. McLawhorn,D. Leeser,L. Rebellato,M. Everly

2018AMERICAN JOURNAL OF TRANSPLANTATION（2018）引用：1

引用

加入学术空间

6The Value of Serum Dilution on DSA Outcome Analysis in Renal Transplantation.

W. Huang,L. Rebellato,K. Briley,P. Bolin,S. Kendrick,A. Maldonado,D. Leeser,C. Haisch,M. Everly

2018AMERICAN JOURNAL OF TRANSPLANTATION（2018）

引用

加入学术空间

7Not All HLA Mismatches Are Equal: Determining the Relative De Novo DSA Induction Capacity of HLA Mismatches.

V. Jucaud,L. Rebellato,K. Briley,A. Maldonado,C. Haisch,P. Bolin,S. Kendrick,H. Jones,K. McLawhorn,D. Leeser,M. Everly

2018AMERICAN JOURNAL OF TRANSPLANTATION（2018）引用：1

引用

加入学术空间

8De Novo DSA Positivity Is Associated with a Higher Rate of Post-Transplant Bacterial and Viral Infections

A. Brooks,L. Rebellato,K. Briley,P. Bolin,S. Kendrick,A. Maldonado,C. Haisch,M. Everly

2017AMERICAN JOURNAL OF TRANSPLANTATION（2017）

引用

加入学术空间

9IgG Dilutions, Subclasses, C1q, and IgM: Determining Relevant Testing for De Novo DSA and Outcome Prediction.

M. Everly,L. Rebellato,C. Haisch,K. Briley,P. Bolin,S. Kendrick, C. Morgan,A. Maldonado,A. Nguyen,P. Terasaki

2016AMERICAN JOURNAL OF TRANSPLANTATION（2016）

引用

加入学术空间

10The levels of de novo HLA antibodies are determined by soluble B cell-activating factor belonging to the TNF family (BAFF) post transplantation

Junchao Cai, W. Huang,L. M. Rebellato,C. E. Haisch,K. P. Briley,P. Bolin,S. A. Kendrick,C. Morgan,P. I. Terasaki,M. J. Everly

2016TRANSPLANTATION（2016）

引用

加入学术空间

11Predicting the Timing of Graft Failure in De Novo DSA Positive Patients.

M. Everly,L. Rebellato,C. Haisch,K. Briley,P. Bolin,S. Kendrick, C. Morgan,A. Maldonado,A. Nguyen,P. Terasaki

2016AMERICAN JOURNAL OF TRANSPLANTATION（2016）

引用

加入学术空间

12Pre-Transplant IgM to Post-Transplant IgG DSA Conversion May Be Affected by Immunosuppression.

A. Nguyen,M. Everly,L. Rebellato,C. Haisch,K. Briley,P. Bolin,S. Kendrick, C. Morgan,A. Maldonado,P. Terasaki

2016AMERICAN JOURNAL OF TRANSPLANTATION（2016）

引用

加入学术空间

13African-American Primary Renal Transplant Recipients Are at a Significantly Higher Risk to Develop De Novo DSA.

M. Everly,L. Rebellato,C. Haisch,K. Briley,P. Bolin,S. Kendrick, C. Morgan,A. Maldonado,A. Nguyen,P. Terasaki

2016AMERICAN JOURNAL OF TRANSPLANTATION（2016）

引用

加入学术空间

14Role of Cmv, Bkv, and Immunosupression Non-Adherence in Early and Late De Novo Donor Specific Anti-Hla Antibody Development and Outcomes

M. Everly,L. Rebellato,K. Briley,A. Maldonado,P. Bolin,C. Haisch,W. Kendrick,S. Kendrick, C. Morgan,R. Harland,P. Terasaki

2015AMERICAN JOURNAL OF TRANSPLANTATION（2015）

引用

加入学术空间

15Early Clinical Indicators of Long Term Survival and Allograft Loss Following De Novo DSA. A 15-Year Longitudinal Study

M. Everly,L. Rebellato,K. Briley,A. Maldonado,P. Bolin,C. Haisch,W. Kendrick,S. Kendrick, C. Morgan,R. Harland,P. Terasaki

2015AMERICAN JOURNAL OF TRANSPLANTATION（2015）

引用

加入学术空间

16Intermittent High Dose Intravenous Immunoglobulin As Treatment for Donor Specific Antibodies in Renal Transplant Recipients

P. Bolin,K. Parker, F. Rana, W. Bryant, P. Jawa,R. Harland

2015AMERICAN JOURNAL OF TRANSPLANTATION（2015）

引用

加入学术空间

17Onset and Progression of De Novo Donor‐specific Anti‐human Leukocyte Antigen Antibodies after BK Polyomavirus and Preemptive Immunosuppression Reduction

G Dieplinger,M J Everly,K P Briley,C E Haisch,P Bolin,A Q Maldonado,W T Kendrick,S A Kendrick, C Morgan,P I Terasaki,L M Rebellato

Background. BK polyomavirus (BKPyV) viremia/nephropathy and reduction in immunosuppression following viremia may increase the risk of alloimmune activation and allograft rejection. This study investigates the impact of BKPyV viremia on de novo donor anti-human leukocyte antigen (HLA)-specific antibodies (dnDSA).Patients and methods. All primary renal transplants at East Carolina University from March 1999 to December 2010, with at least 1 post-transplant BKPyV viral load testing, were analyzed. Patients were negative for anti-HLA antibodies to donor antigens (tested via single antigen beads) at transplantation and at first BKPyV testing.Results. Nineteen of 174 patients (11%) tested positive for BKPyV viremia. Within 24 months of BKPyV viremia detection, 79% of BKPyV-viremic patients developed dnDSA. Only 20% of BKPyV viremia-persistent cases, compared to 86% of BKPyV viremia-resolved cases, developed dnDSA (P = 0.03). Poor allograft survival was evident in BKPyV viremia-persistent patients (60% failure by 2 years post BKPyV diagnosis) and in BKPyV viremia-resolved patients with dnDSA (5-year post BKPyV diagnosis allograft survival of 48%).Conclusions. Post-transplant BKPyV viremia and preemptive immunosuppression reduction is associated with high rates of dnDSA. When preemptively treating BKPyV viremia, dnDSA should be monitored to prevent allograft consequences.

2015Transplant infectious disease an official journal of the Transplantation Society（2015）引用：33

引用

加入学术空间

18Improved Long-Term Graft Survival in Renal Transplant Recipients With Donor Specific Antibodies (DSA) After Mycophenolic Acid Escalation

L. Rebellato,K. Parker, F. Rana,S. Kendrick, C. Morgan,C. Haisch,M. Everly,R. Harland,P. Bolin

2015AMERICAN JOURNAL OF TRANSPLANTATION（2015）

引用

加入学术空间

19Actual 5-Year Post-De Novo Dsa Outcomes in Low Risk Primary Kidney Transplant Recipients.

M. Everly,L. Rebellato,C. Haisch,K. Briley,P. Bolin,W. Kendrick,S. Kendrick, C. Morgan,G. Dieplinger,A. Maldonado,R. Harland,P. Terasaki

2014Transplantation（2014）

引用

加入学术空间

20Changes in Successive Measures of De Novo Dsa Intensity Predict Development of Renal Allograft Dysfunction.

G. Dieplinger,M. Everly,L. Rebellato,C. Haisch,K. Briley,P. Bolin,W. Kendrick,S. Kendrick, C. Morgan,R. Harland,P. Terasaki

2014Transplantation（2014）

引用

加入学术空间

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

Kendrick Scott A

Kendrick Scott A合作论文数37

Matthew J Everly合作论文数36

Paul Terasaki (寺崎一郎)合作论文数Department of Surgery, School of Medicine, University of California, Los Angeles30

Kimberly P. Briley

Kimberly P. Briley合作论文数28

L. Rebellato

L. Rebellato合作论文数28

Christoph Haisch

Christoph Haisch合作论文数27

Kendrick William T

Kendrick William T合作论文数24

Robert Harland合作论文数Department of Surgery, University of Massachusetts Medical School24

Craig Morgan合作论文数Department of Health Service and Population Research, School of Mental Health & Psychological Sciences, Institute of Psychiatry, Psychology & Neuroscience, King’s College London20

A. Maldonado

A. Maldonado合作论文数17

C. E. Haisch

C. E. Haisch合作论文数11

K. P. Briley

K. P. Briley合作论文数10

L. M. Rebellato

L. M. Rebellato合作论文数9

Parker Karen

Parker Karen合作论文数9

Georg Dieplinger合作论文数8

Miyuki Ozawa

Miyuki Ozawa合作论文数8

David B Leeser合作论文数7

Paul G. Catrou

Paul G. Catrou合作论文数7

H. Jones

H. Jones合作论文数6

K. McLawhorn

K. McLawhorn合作论文数6

Nguyen Huynh Bao Anh合作论文数5

Junchao Cai (蔡俊超)合作论文数Zhongshan School of Medicine, Sun Yat-Sen University4

Vadim Jucaud合作论文数3

P Catrou

P Catrou合作论文数3

W. Huang

W. Huang合作论文数2

L. M. Rebellato-deVente

L. M. Rebellato-deVente合作论文数2

A. Q. Maldonado

A. Q. Maldonado合作论文数2

P. Wu

P. Wu合作论文数2

Taniguchi Michiko

Taniguchi Michiko合作论文数2

J Hopfield

J Hopfield合作论文数2

Rk Detwiler

Rk Detwiler合作论文数2

K Schulze-Forster

K Schulze-Forster合作论文数1

A. Babu

A. Babu合作论文数1

H K Singh

H K Singh合作论文数1

J. Petersen

J. Petersen合作论文数1

Debra Scarlata

Debra Scarlata合作论文数1

Susan R. Gerkin

Susan R. Gerkin合作论文数1

Satoru Kawakita

Satoru Kawakita合作论文数Terasaki Institute for Biomedical Innovation1

J. L. Beaumont

J. L. Beaumont合作论文数1

I. Purnajo

I. Purnajo合作论文数1

Roy D. Bloom合作论文数Division of Renal Electrolyte and Hypertension, Department of Medicine, Perelman School of Medicine, University of Pennsylvania1

Wei Huang (黄卫)合作论文数School of Chemistry and Chemical Engineering, Shanghai Jiao Tong University1

Mirza Raza M

Mirza Raza M合作论文数1

J. Charles Jennette合作论文数Department of Pathology and Laboratory Medicine, School of Medicine, The University of North Carolina at Chapel Hil1

Rachel Ward

Rachel Ward合作论文数Alfred Health Melbourne1

Karlene Hewan-Lowe

Karlene Hewan-Lowe合作论文数1

Jennifer L Beaumont合作论文数Terasaki Research Institute, Los Angeles, CA1

Duška Dragun合作论文数Forschungslabors für Nephrologie und Immunologie, Charité – Universitätsmedizin Berlin;Biomedical Innovation Academy, Berliner Instituts für Gesundheitsforschung, Charité – Universitätsmedizin Berlin1

Stanley R. Mandel

Stanley R. Mandel合作论文数1

相似学者

Kendrick Scott A

Kendrick Scott A

Matthew J Everly

Kimberly P. Briley

Kimberly P. Briley

Christoph Haisch

Christoph Haisch

Kendrick William T

Kendrick William T

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn